Filter
138
Filtered Results: 138
Text search:
Novartis
Featured
Recommendations
11
New Publications
23
Language
Document type
No document type
65
Studies & Reports
46
Guidelines
14
Strategic & Response Plan
7
Situation Updates
2
Fact sheets
2
Manuals
1
Resource Platforms
1
Countries / Regions
Global
9
Africa
6
South Africa
6
Tanzania
5
India
4
Russia
3
Indonesia
3
Ukraine
2
Ghana
2
Nigeria
2
Philippines
2
Latin America and the Carribbean
2
Germany
2
Western and Central Europe
2
Nepal
1
Kenya
1
Sierra Leone
1
Chile
1
Malawi
1
Mozambique
1
Cambodia
1
Asia
1
Venezuela
1
Bangladesh
1
Brazil
1
Namibia
1
Ethiopia
1
Authors & Publishers
Publication Years
Category
Countries
35
Public Health
15
Clinical Guidelines
8
Pharmacy & Technologies
6
Women & Child Health
1
Key Resources
1
Toolboxes
Mental Health
27
NCDs
24
NTDs
21
COVID-19
7
TB
6
Pharmacy
6
AMR
5
Disability
4
Planetary Health
4
Global Health Education
3
Rapid Response
2
HIV
2
Ebola & Marburg
2
Caregiver
2
Refugee
1
Chagas disease affects approximately 6 million people, mainly in Latin America. Less than 1% of affected individuals receive proper antiparasitic treatment, and current drugs are inadequate to fight the entire spectrum of the disease. Against this background, Novartis is pursuing an end-to-end appro...
Guidelines for Primary, Secondary and Tertiary Level Care
WHO promotes the inclusion of foodborne trematodiases among the targets of preventive chemotherapy interventions. With the aim of providing access to quality medicines, WHO has negotiated with Novartis Pharma AG whereby Novartis donates triclabendazole for the treatment of fascioliasis and paragonim...
The 2018 Access to Medicine Index finds that the pharmaceutical industry continues to mature in its approach to access to medicine, with models for good practice in areas such as access planning and licensing. GSK retains its No. 1 position, as Novartis moves up into 2nd. Takeda rises furthest in 20...
Introdução
Capítulo A.9
Edição em Português
Editor: Flávio Dias Silva.
Tradutores: Letícia Tomaz Oliveira, Luciano da Silva Quadros
Troubles Anxieux
Chapitre F.3
Edition en français
Traduction : Alexis Revet
Sous la direction de : Jean-Philippe Raynaud Avec le soutien de la SFPEADA
This paper explores the angles and opportunities of digital health, with a look
at digital innovation and its potential to support patients with circulatory diseases.
In reviewing developments in the field, current applications as well as gaps, the paper aims to support policymakers in leveraging ...
(15 April 2020, BST 17:00 hours)
Actions Taken from Bangladesh Red Crescent Society (BDRCS):
9292 Number of staff and RCY/ CPP/ Camp/ Community volunteers being mobilized throughout the country.
10116 Set of PPE provided to individuals working on COVID-19 response.
130,851 Number of Total Peop...
Asthma is one of the neglected diseases in Africa with a high prevalence. Allergic fungal diseases have been reported to complicate asthma progression and treatment outcomes. However, data about fungal asthma and its associated complications are limited in Africa. We aimed to estimate the burden of ...
Global progress against cardiovascular disease (CVD) is flatlining.
Though rates of CVD deaths globally have fallen in the last three
decades, this trend has begun to stall and, without concerted
efforts, is at risk of reversing.
Introduction
Chapter A.9
Anxiety disorders
Chapter F.3
This publication is intended for professionals training or practicing in mental health and not for the general public. The opinions expressed are those of the authors and do not necessarily represent the views of the Editor or IACAPAP. This publication seeks to describe the best treatments and pract...
Anxiety disorders
Chapter F.2
Introductión
Capítulo A.9
Edición: Matías Irarrázaval & Andres Martin
Traducción: Fernanda Prieto-Tagle & José Montejo
В настоящем отчете (это уже четвертое его издание) анализируются препятствия и факторы, затрудняющие доступ к препаратам для лечения лекарственно-устойчивого туб...
The Antimicrobial Resistance Benchmark has evaluated for the second time how the most important players in the antibiotic market are addressing the rise of resistance and the global need for appropriate access to antibiotics. Although we can see progress — it’s hanging by a thread.
We have reac...
Externalizing disorders
Chapter 1.1
